Related Experiment Video
Updated: May 8, 2026
10:50
Using In Vitro Fluorescence Resonance Energy Transfer to Study the Dynamics Of Protein Complexes at a Millisecond Time Scale
Published on: March 14, 2019
Cullin 3 as a novel target in diverse pathologies
Ana Cristina Andérica-Romero1, Irma Gabriela González-Herrera, Abel Santamaría
1Facultad de Química, Departamento de Biología, Universidad Nacional Autónoma de México (UNAM), Ciudad Universitaria, 04510 México D.F., México.
Redox Biology
|September 12, 2013
Summary
The ubiquitin-proteasome system (UPS) is crucial for cell protein disposal. Malfunctioning of cullin 3 (Cul3), an E3 ligase component, is implicated in diseases like cancer and neurodegeneration, offering new drug discovery avenues.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- The ubiquitin-proteasome system (UPS) is vital for cellular protein homeostasis.
- Dysregulation of E3 ubiquitin ligases within the UPS is linked to cancer and neurodegenerative diseases.
- Cullins are scaffold proteins essential for E3 ligase function and substrate specificity.
Purpose of the Study:
- To review recent advances in the basic biology of cullin 3 (Cul3).
- To explore the role of Cul3 in disease pathogenesis.
- To identify potential therapeutic strategies targeting Cul3 for drug discovery.
Main Methods:
- Literature review of recent research on Cul3 biology.
- Analysis of data linking Cul3 to various diseases.
- Exploration of Cul3's potential as a drug target.
Main Results:
- Cullin 3 (Cul3) is emerging as a key protein in the development of multiple diseases.
- E3 ligases, including Cul3, regulate critical cellular processes like cell cycle and gene transcription.
- Cul3's involvement in disease pathology is increasingly recognized.
Conclusions:
- Cul3 plays a significant role in the etiopathology of various disorders.
- Understanding Cul3 biology is essential for developing targeted therapies.
- Cul3 represents a promising target for future drug discovery efforts in cancer and neurodegeneration.
Related Concept Videos
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:04Covalently Linked Protein Regulators
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
These groups modify specific amino acids in a protein.
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
02:18The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...